Mountain Pacific Investment Advisers LLC Has $570,000 Stake in Merit Medical Systems, Inc. $MMSI

Mountain Pacific Investment Advisers LLC cut its stake in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 92.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 6,848 shares of the medical instruments supplier’s stock after selling 87,118 shares during the quarter. Mountain Pacific Investment Advisers LLC’s holdings in Merit Medical Systems were worth $570,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently modified their holdings of the company. AQR Capital Management LLC raised its position in Merit Medical Systems by 7.3% in the 1st quarter. AQR Capital Management LLC now owns 16,361 shares of the medical instruments supplier’s stock valued at $1,730,000 after buying an additional 1,114 shares during the last quarter. Goldman Sachs Group Inc. grew its stake in shares of Merit Medical Systems by 16.9% in the 1st quarter. Goldman Sachs Group Inc. now owns 719,313 shares of the medical instruments supplier’s stock worth $76,039,000 after acquiring an additional 103,878 shares in the last quarter. Park Avenue Securities LLC grew its stake in shares of Merit Medical Systems by 11.9% in the 2nd quarter. Park Avenue Securities LLC now owns 6,402 shares of the medical instruments supplier’s stock worth $598,000 after acquiring an additional 683 shares in the last quarter. Maseco LLP bought a new position in shares of Merit Medical Systems during the second quarter valued at about $28,000. Finally, Public Employees Retirement System of Ohio boosted its holdings in Merit Medical Systems by 6.5% during the second quarter. Public Employees Retirement System of Ohio now owns 66,102 shares of the medical instruments supplier’s stock worth $6,179,000 after purchasing an additional 4,012 shares during the last quarter. Hedge funds and other institutional investors own 99.66% of the company’s stock.

Merit Medical Systems Stock Performance

Shares of MMSI opened at $83.45 on Thursday. Merit Medical Systems, Inc. has a 1 year low of $78.12 and a 1 year high of $111.45. The company has a debt-to-equity ratio of 0.48, a current ratio of 4.28 and a quick ratio of 2.86. The stock’s fifty day moving average price is $86.10 and its two-hundred day moving average price is $85.94. The firm has a market cap of $4.95 billion, a PE ratio of 42.79, a PEG ratio of 2.22 and a beta of 0.62.

Merit Medical Systems (NASDAQ:MMSI) last posted its quarterly earnings results on Thursday, October 30th. The medical instruments supplier reported $0.92 earnings per share for the quarter, topping the consensus estimate of $0.82 by $0.10. Merit Medical Systems had a return on equity of 14.27% and a net margin of 8.02%.The company had revenue of $384.16 million during the quarter, compared to the consensus estimate of $371.69 million. During the same quarter in the prior year, the company earned $0.86 EPS. The firm’s quarterly revenue was up 13.0% compared to the same quarter last year. Merit Medical Systems has set its FY 2025 guidance at 3.660-3.790 EPS. On average, equities research analysts forecast that Merit Medical Systems, Inc. will post 3.37 EPS for the current year.

Insider Buying and Selling at Merit Medical Systems

In other news, Chairman Fred P. Lampropoulos sold 25,000 shares of the business’s stock in a transaction that occurred on Friday, November 21st. The shares were sold at an average price of $87.31, for a total value of $2,182,750.00. Following the sale, the chairman owned 1,029,955 shares of the company’s stock, valued at $89,925,371.05. The trade was a 2.37% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders have sold a total of 60,000 shares of company stock valued at $5,189,900 in the last three months. 3.20% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several research firms have commented on MMSI. Robert W. Baird set a $108.00 price objective on shares of Merit Medical Systems in a research note on Tuesday, December 16th. Piper Sandler reaffirmed an “overweight” rating and issued a $109.00 target price (up from $105.00) on shares of Merit Medical Systems in a report on Friday, October 31st. Wells Fargo & Company decreased their price target on Merit Medical Systems from $103.00 to $95.00 and set an “overweight” rating for the company in a research report on Friday, November 14th. Zacks Research lowered Merit Medical Systems from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 18th. Finally, Needham & Company LLC reiterated a “buy” rating and set a $108.00 target price on shares of Merit Medical Systems in a research note on Friday, January 9th. Eight equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Merit Medical Systems presently has a consensus rating of “Moderate Buy” and a consensus target price of $105.88.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.